Indiana's Methamphetamine Crisis: What Hoosiers Need to Know
While opioids dominate headlines, methamphetamine use has surged across Indiana. This guide covers the scope of the crisis, signs of meth addiction, and where to find treatment.
Indiana’s opioid crisis has rightly captured public attention — but quietly, another epidemic has been building alongside it. Methamphetamine use has surged dramatically across the state, and in many rural Indiana counties, meth has now overtaken opioids as the primary driver of overdose deaths and addiction treatment admissions.
Understanding what’s happening — and what can be done — is the first step toward protecting Hoosier families and communities.
The Scope of Indiana’s Meth Problem
The data from the Indiana State Department of Health (ISDH) and federal agencies paints a stark picture:
- Methamphetamine-involved overdose deaths in Indiana increased by more than 300% over the past decade, according to ISDH mortality data.
- A significant portion of drug overdose deaths now involve both meth and an opioid — particularly fentanyl — a phenomenon known as “meth-opioid polysubstance use” that dramatically increases lethality.
- The Indiana Family and Social Services Administration (FSSA) reports that methamphetamine is consistently among the top substances cited at addiction treatment admission across the state.
- In rural Indiana counties — particularly in the south and central regions — methamphetamine prevalence in criminal justice data now rivals or exceeds opioid-related offenses.
The national picture echoes Indiana’s: according to SAMHSA’s 2023 National Survey on Drug Use and Health (NSDUH), approximately 2.7 million Americans reported using methamphetamine in the past year. The CDC has documented that stimulant-involved overdose deaths — primarily methamphetamine — more than tripled nationally between 2013 and 2023.
Why Meth Has Surged
Several factors explain the resurgence of methamphetamine after a relative decline in the 2000s:
Supply has transformed. The meth of today is fundamentally different from the product manufactured in small domestic labs a generation ago. Highly potent, inexpensive methamphetamine produced in Mexico by transnational criminal organizations now dominates the supply. This “P2P meth” (named for the production precursor used) is significantly cheaper and far more potent than domestically produced meth — contributing both to higher rates of addiction and more severe health consequences.
Domestic lab restrictions reduced but didn’t eliminate the problem. Indiana and other states passed laws restricting pseudoephedrine sales in the mid-2000s, which did reduce domestic “shake-and-bake” labs. But the supply gap was rapidly filled by Mexican imports, and at a lower price point.
The opioid crisis opened a door. As opioid prescribing was restricted and overdose deaths mounted, some substance users — particularly those who wanted a stimulant rather than a depressant — turned to meth. Others began using meth alongside opioids, creating dangerous polysubstance patterns.
Economic despair drives demand. Areas of Indiana hit hardest by manufacturing job loss, poverty, and limited social mobility have the highest rates of methamphetamine use. NIDA’s research on addiction consistently identifies economic instability and limited opportunity as significant risk factors.
What Methamphetamine Does to the Body and Brain
Methamphetamine is a powerful central nervous system stimulant. It causes a massive surge of dopamine — the brain’s reward neurotransmitter — producing an intense rush of euphoria, energy, and confidence. Unlike cocaine, which metabolizes quickly, meth’s effects can last 8 to 12 hours.
But the neurological consequences of regular meth use are severe:
Dopamine system damage: Chronic meth use physically damages dopamine receptors and the neurons that produce dopamine. This creates a state in which the brain struggles to feel pleasure from anything other than meth — a condition called anhedonia. Recovery of dopamine function can take one to two years of abstinence, and some damage may be permanent.
Cognitive impairment: Meth causes damage to the prefrontal cortex, impairing executive function — decision-making, impulse control, planning, and emotional regulation. Users may experience memory problems, difficulty concentrating, and slowed processing that persist well into recovery.
Psychosis: High doses or long-term use can cause meth-induced psychosis, characterized by paranoia, hallucinations, and delusions that can be indistinguishable from schizophrenia. While meth-induced psychosis typically resolves with abstinence, it can persist for months in heavy users and may trigger lasting vulnerability in those with underlying psychiatric conditions.
Cardiovascular damage: Meth places extreme stress on the cardiovascular system, increasing heart rate and blood pressure and raising the risk of heart attack, stroke, and sudden cardiac death — even in young, otherwise healthy individuals.
Physical appearance: Accelerated aging, severe dental decay (“meth mouth”), skin sores from compulsive picking, and dramatic weight loss are common in chronic meth users.
Signs of Methamphetamine Addiction
Recognizing meth addiction in a loved one can be difficult, particularly in early stages. Signs to watch for include:
Behavioral changes:
- Dramatic increase in energy, talkativeness, and activity (especially at night)
- Periods of no sleep lasting 24 to 72 hours, followed by extended crashes
- Erratic, paranoid, or aggressive behavior
- Sudden loss of interest in family, work, or activities
- Neglect of children, pets, or household responsibilities
- Secretive behavior, disappearing for long stretches of time
- Dramatic mood swings — from elated and grandiose to depressed and irritable
Physical signs:
- Extreme weight loss
- Sores on the face, arms, or body (from compulsive picking)
- Deteriorating dental health
- Dilated pupils
- Increased body temperature and sweating
- Twitching, facial tics, or repetitive body movements
Psychological signs:
- Paranoia or suspiciousness out of proportion to circumstances
- Hallucinations — seeing, hearing, or feeling things that aren’t there
- Intense focus on a meaningless task for hours (a phenomenon called “tweaking”)
- Severe depression during periods of not using
The Challenge of Meth Treatment
Unlike opioid addiction, there is currently no FDA-approved medication specifically for methamphetamine use disorder. This does not mean treatment is ineffective — far from it — but it does mean behavioral therapies play a central role.
Contingency management is currently the most evidence-supported treatment for stimulant use disorders. It uses positive reinforcement — rewards like gift cards, prizes, or privileges — for verified abstinence. Multiple large studies have demonstrated that contingency management significantly improves treatment retention and abstinence rates. The Veterans Affairs system has implemented it nationally.
Cognitive behavioral therapy (CBT) helps people identify the thoughts, triggers, and situations that drive meth use and develop concrete coping strategies. It is considered a foundational treatment.
The Matrix Model is a structured intensive outpatient program specifically designed for stimulant use disorders, combining CBT, motivational interviewing, family education, and peer support. It is endorsed by SAMHSA and has strong evidence for meth treatment specifically.
Residential treatment may be necessary for people with severe addiction, co-occurring psychiatric disorders (particularly meth-induced psychosis), or unstable living situations. Indiana has residential treatment capacity through FSSA-certified programs across the state.
Peer support and recovery housing are often critical for long-term recovery from meth, particularly given the prolonged nature of post-acute withdrawal syndrome (PAWS) — a period of months to years during which people may experience cognitive difficulties, depression, and powerful cravings.
Finding Treatment in Indiana
Indiana residents seeking meth treatment have several resources:
- FSSA’s Behavioral Health Division maintains a treatment locator at in.gov/fssa/
- SAMHSA’s National Helpline: 1-800-662-4357 (free, confidential, 24/7)
- findtreatment.gov: SAMHSA’s national treatment facility locator
- Indiana 211: Connect to local social services and treatment navigation by dialing 211
- Indiana Recovery Network: A peer-led organization connecting Hoosiers to recovery resources statewide
If you or a loved one is in a mental health crisis related to meth use — including psychosis, severe agitation, or thoughts of self-harm — call 911 or go to the nearest emergency room.
Get Help Now
Methamphetamine addiction is devastating — but recovery is absolutely possible. People who once felt controlled by meth have gone on to rebuild their lives, their relationships, and their health. Indiana has treatment programs staffed by people who understand what you’re going through and have helped thousands of Hoosiers find their way out.
Call the Indiana Addiction Hotline today. Our counselors are available around the clock and can help you find local treatment that fits your situation — no matter where in Indiana you are, or how long you’ve been struggling. The call is free, confidential, and the first step toward a different kind of life.